bispecifics for relapsed/refractory diffuse large b-cell lymphoma (r/r dlbcl)- blood cancers onctalk
Published 8 months ago • 40 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
1:19
q&a: do bispecifics cure diffuse large b-cell lymphoma? - blood cancer onctalk 2023
-
6:06
bispecific antibody treatment in non-hodgkin lymphoma: epcoritamab - blood cancers onctalk 2023
-
2:52
bispecific antibody treatment in non-hodgkin lymphoma: glofitamab - blood cancers onctalk 2023
-
2:47
efficacy of epcoritamab and glofitamab in diffuse large b-cell lymphoma - blood cancers onctalk 2023
-
3:53
the future of bispecific antibodies - blood cancer onctalk 2023
-
1:56
types of bispecific antibodies - blood cancer onctalk 2023
-
3:36
treatment options for relapsed diffuse large b-cell lymphoma blood cancer video library
-
3:36
q&a: financial or location limitations to bispecific antibody treatments? -blood cancer onctalk 2023
-
4:20
bispecific treatments for multiple myeloma - blood cancers video library
-
1:05
q&a: does bispecific treatment for lymphoma affect fertility? - blood cancer onctalk 2023
-
3:56
bispecific antibodies in myeloma: approvals and clinical trials - blood cancer onctalk 2023
-
4:53
immunotherapy treatments b-cell non-hodgkin's: bispecific antibodies - blood cancer video library
-
1:37
pros and cons of bispecific antibodies - blood cancer onctalk 2023
-
3:45
b-cell lymphoma: an overview - blood cancer video library 2023
-
2:06
patient role in bispecific antibody treatment - blood cancer onctalk 2023
-
2:57
future directions of b-cell lymphoma treatment - blood cancer video library 2023
-
2:53
management of bispecific antibodies side effects - blood cancer onctalk 2023
-
3:02
efficacy of epcoritamab and glofitamab in diffuse large b-cell lymphoma
-
4:28
bispecific antibody clinical trials - blood cancer video library 2023